ZSAN Zosano Pharma Corp

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications.

$2.10
As of 05/20/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2015
Outstanding shares:  4,902,260
Average volume:  237,951
Market cap:   $10,343,769
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -0.47
PB ratio:   0.73
PS ratio:   19.63
Return on equity:   -392.74%
Net income %:   -10,472.87%